U
AMAG

UBS’s AMAG Pharmaceuticals AMAG Stock Holding History

UBS’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$1K Sell
32
-2,914
-99% -$62.1K ﹤0.01% 10211
2014
Q2 		$61K Sell
2,946
-351
-11% -$6.49K ﹤0.01% 6616
2014
Q1 		$63K Buy
3,297
+2,035
+161% +$43.2K ﹤0.01% 6552
2013
Q4 		$31K Buy
1,262
+1,155
+1,079% +$27.2K ﹤0.01% 7609
2013
Q3 		$2K Sell
107
-105
-50% -$2.48K ﹤0.01% 10010
2013
Q2 		$5K Buy
+212
New +$4.67K ﹤0.01% 9289

Other funds holding AMAG

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

UBS's AMAG Position: Q3 2014 in Review

UBS reduced its AMAG Pharmaceuticals (AMAG) stake by 99% in Q3 2014, selling an estimated $62.1K and leaving 32 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #10211.

UBS first reported a position in AMAG in Q2 2013 and has held it in 6 quarters since. The position peaked at $63K in Q1 2014. 113 funds tracked by Wall St. Rank hold AMAG as of Q3 2014.

  • UBS held 32 shares of AMAG Pharmaceuticals worth $1K as of Q3 2014.
  • UBS sold 2,914 AMAG Pharmaceuticals shares in Q3 2014, an estimated $62.1K.
  • AMAG Pharmaceuticals made up ﹤0.01% of UBS's portfolio in Q3 2014, its #10211 holding.
  • UBS first reported a position in AMAG Pharmaceuticals in Q2 2013 and has held it in 6 quarters since.
  • UBS's AMAG Pharmaceuticals position peaked at $63K in Q1 2014.
  • 113 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.